← Guides

How should incoming CoAs be reviewed under 21 CFR 211.84?

By Savi C., Co-Founder · Published Nov 16, 2026

What 211.84 actually requires

Under 211.84(a), each lot of components, containers and closures is withheld from use until it has been sampled, tested or examined as appropriate and released by the quality control unit. Paragraph (d)(1) requires at least one test to verify the identity of each component, using a specific identity test where one exists. Paragraph (d)(2) requires each component to be tested against all appropriate written specifications for purity, strength and quality.

The same paragraph is where the CoA comes in. In lieu of that testing, a report of analysis may be accepted from the supplier, provided the manufacturer conducts at least one specific identity test and establishes the reliability of the supplier analyses through appropriate validation of the supplier test results at appropriate intervals. For containers and closures, (d)(3) sets the parallel rule: a supplier certificate of testing may be accepted if the manufacturer performs at least a visual identification and validates the supplier results at appropriate intervals. Lots that meet specification may be approved under (e), and lots that do not must be rejected.

In short, the CoA replaces some of your testing. It never replaces your identity test, and it is only acceptable from a supplier whose results you have checked yourself.

Establishing that a supplier is reliable

The regulation does not say how many lots to test or how often to re-check. For APIs, ICH Q7 gives a widely used pattern in section 7.31: supplier approval should include evidence, such as past quality history, that the supplier can consistently meet specifications, and full analyses should be conducted on at least three batches before reducing in-house testing. After that, a full analysis should still be performed at appropriate intervals and compared with the certificates.

Some components get no reduced testing at all. FDA guidance issued in May 2023 on glycerin, propylene glycol and other high-risk components recommends testing representative samples from every container of every lot for diethylene glycol and ethylene glycol, because contamination has varied from container to container.

Checklist for reviewing each incoming CoA

Is this the right document

  • Material name, grade and supplier lot number match the container labels and the receiving record
  • The certificate names the original manufacturer, and if issued by a repacker or distributor, references the original certificate
  • Dated and signed by the supplier quality unit, as ICH Q7 section 11.43 expects for APIs and intermediates
  • Expiry or retest date stated and not exceeded

Does it meet your specification

  • Every test in your specification appears on the certificate, not just the tests the supplier chose to report
  • Methods are the compendial or agreed methods, at the current revision
  • Acceptance limits on the certificate are the same as or tighter than yours
  • Numerical results are reported as numbers, not just "complies", and every result is inside your limit

Can you still rely on this supplier

  • Supplier is on the approved list for this material and site
  • Your own identity test was performed on this lot and passed
  • The periodic full-test comparison is current, with no unexplained disagreement between your results and theirs
  • Material is not on your list of components that require full testing regardless of the certificate

How Litewave fits

Certificate review is repetitive matching: the same fields checked against the same specification, lot after lot. Litewave reads paper or electronic records, including supplier certificates, checks every entry against your specifications, and shows QA only the exceptions, each linked to the page it came from. Litewave proposes, qualified people approve, and the release decision stays with your quality control unit.

Questions we get asked

Can we skip identity testing if the supplier is approved?

Not under 211.84 for drug components. Paragraph (d)(2) allows a supplier report of analysis only if you conduct at least one specific identity test yourself. For containers and closures, at least a visual identification is required.

How often do we need to validate supplier CoAs?

The regulation says at appropriate intervals and leaves the frequency to you. Set it by risk in a written procedure, base the initial qualification on full testing of several lots, and re-check periodically by comparing your own full results with the supplier certificate.

What should happen when our result disagrees with the CoA?

Treat it as a discrepancy to investigate, not a retest until it passes. The outcome can affect the lot, the supplier status and every earlier lot accepted on that supplier’s certificates.

Sources

  1. 21 CFR 211.84, Testing and approval or rejection of components, drug product containers and closures (eCFR)
  2. ICH Q7, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  3. FDA, Testing of Glycerin, Propylene Glycol and other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol (May 2023)